Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PREPARE: PRevention Using EPA Against coloREctal Cancer

NCT04216251 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04216251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04216251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PREPARE: PRevention Using EPA Against coloREctal Cancer
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
December 9, 2020
Completion date
September 30, 2022
Enrollment
81 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal adenoma, colorectal cancer, eicosapentaenoic acid, endoscopic surgery, gastrointestinal microbiome